These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2935075)
21. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. Ringdén O; Lönnqvist B; Paulin T; Ahlmén J; Klintmalm G; Wahren B; Lernestedt JO J Antimicrob Chemother; 1986 Mar; 17(3):373-87. PubMed ID: 3009383 [TBL] [Abstract][Full Text] [Related]
22. Interactions of [14C]phosphonoformic acid with renal cortical brush-border membranes. Relationship to the Na+-phosphate co-transporter. Szczepanska-Konkel M; Yusufi AN; Dousa TP J Biol Chem; 1987 Jun; 262(17):8000-10. PubMed ID: 2954950 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Sjövall J; Bergdahl S; Movin G; Ogenstad S; Saarimäki M Antimicrob Agents Chemother; 1989 Jul; 33(7):1023-31. PubMed ID: 2528939 [TBL] [Abstract][Full Text] [Related]
24. The action of epidermal growth factor (EGF) is limited to specific phases of the cell cycle in an EGF dependent colonic cell line. Sizeland A; Bol S; Burgess AW Growth Factors; 1991; 4(2):129-43. PubMed ID: 2049180 [TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids increase the length of the G2 and M phases of the HeLa S3 cell cycle. Fanger BO; Schreifer J; Cidlowski JA J Steroid Biochem; 1987 Sep; 28(3):345-7. PubMed ID: 3657157 [TBL] [Abstract][Full Text] [Related]
26. Mode of action of phosphonoformate as an anti-herpes simplex virus agent. Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of foscarnet against viral polymerases. Crumpacker CS Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038 [TBL] [Abstract][Full Text] [Related]
28. Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response? Hansson BG; Riesbeck K; Nordenfelt E; Weiland O Prog Clin Biol Res; 1991; 364():421-7. PubMed ID: 1826956 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir. Al-Samarai A; Kinghorn G; Potter C Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616 [No Abstract] [Full Text] [Related]